(Adds dropped words "says Brigatinib's" in headline)
Oct 10 Ariad Pharmaceuticals Inc
* Press release - Ariad presents updated long-term follow-up results from the phase 1/2 trial on investigational drug Brigatinib at 2016 ESMO meeting
* Ariad Pharmaceuticals Inc - safety profile was similar with longer follow-up
* Ariad Pharmaceuticals Inc - in eight Crizotinib-Naive ALK+ NSCLC patients, confirmed ORR was 100% Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.